These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12812348)

  • 1. Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000.
    McLaughlin SI; Radday J; Michel MC; Addiss DG; Beach MJ; Lammie PJ; Lammie J; Rheingans R; Lafontant J
    Am J Trop Med Hyg; 2003 May; 68(5):568-73. PubMed ID: 12812348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration.
    de Rochars MB; Kanjilal S; Direny AN; Radday J; Lafontant JG; Mathieu E; Rheingans RD; Haddix AC; Streit TG; Beach MJ; Addiss DG; Lammie PJ
    Am J Trop Med Hyg; 2005 Nov; 73(5):888-94. PubMed ID: 16282299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae.
    Supali T; Ismid IS; Rückert P; Fischer P
    Trop Med Int Health; 2002 Oct; 7(10):894-901. PubMed ID: 12358626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endpoints for lymphatic filariasis programs.
    Grady CA; de Rochars MB; Direny AN; Orelus JN; Wendt J; Radday J; Mathieu E; Roberts JM; Streit TG; Addiss DG; Lammie PJ
    Emerg Infect Dis; 2007 Apr; 13(4):608-10. PubMed ID: 17553278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment.
    Supali T; Djuardi Y; Pfarr KM; Wibowo H; Taylor MJ; Hoerauf A; Houwing-Duistermaat JJ; Yazdanbakhsh M; Sartono E
    Clin Infect Dis; 2008 May; 46(9):1385-93. PubMed ID: 18419441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka.
    Gunawardena S; Sri Ranganathan S; Fernandopulle R
    Trop Med Int Health; 2008 Sep; 13(9):1153-8. PubMed ID: 18631319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India.
    Kshirsagar NA; Gogtay NJ; Garg BS; Deshmukh PR; Rajgor DD; Kadam VS; Thakur PA; Gupta A; Ingole NS; Lazdins-Helds JK
    Parasitol Res; 2017 Oct; 116(10):2683-2694. PubMed ID: 28785847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India.
    Babu BV; Rath K; Kerketta AS; Swain BK; Mishra S; Kar SK
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):464-9. PubMed ID: 16288792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of methods for estimating drug coverage for filariasis elimination, Leogane Commune, Haiti.
    Mathieu E; Deming M; Lammie PJ; McLaughlin SI; Beach MJ; Deodat DJ; Addiss DG
    Trans R Soc Trop Med Hyg; 2003; 97(5):501-5. PubMed ID: 15307410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole.
    Rizzo JA; Belo C; Lins R; Dreyer G
    Ann Trop Med Parasitol; 2007 Jul; 101(5):423-33. PubMed ID: 17550648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of integrated mass drug administration for neglected tropical diseases in Haiti.
    Goldman AS; Brady MA; Direny A; Desir L; Oscard R; Vely JF; Linehan M; Baker M
    Am J Trop Med Hyg; 2011 Nov; 85(5):826-33. PubMed ID: 22049035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass drug administration to treat lymphatic filariasis.
    Ravindran B
    Lancet; 2002 Jun; 359(9321):1948. PubMed ID: 12057582
    [No Abstract]   [Full Text] [Related]  

  • 13. National mass drug administration costs for lymphatic filariasis elimination.
    Goldman AS; Guisinger VH; Aikins M; Amarillo ML; Belizario VY; Garshong B; Gyapong J; Kabali C; Kamal HA; Kanjilal S; Kyelem D; Lizardo J; Malecela M; Mubyazi G; Nitièma PA; Ramzy RM; Streit TG; Wallace A; Brady MA; Rheingans R; Ottesen EA; Haddix AC
    PLoS Negl Trop Dis; 2007 Oct; 1(1):e67. PubMed ID: 17989784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
    Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL
    Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions of 300 MG diethylcarbamazine, and in a combination of 400 MG albendazole, for a mass annual single dose treatment, in migrant workers in Phang Nga province.
    Yongyuth P; Koyadun S; Jaturabundit N; Jariyahuttakij W; Bhumiratana A
    J Med Assoc Thai; 2007 Mar; 90(3):552-63. PubMed ID: 17427535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
    Horton J; Witt C; Ottesen EA; Lazdins JK; Addiss DG; Awadzi K; Beach MJ; Belizario VY; Dunyo SK; Espinel M; Gyapong JO; Hossain M; Ismail MM; Jayakody RL; Lammie PJ; Makunde W; Richard-Lenoble D; Selve B; Shenoy RK; Simonsen PE; Wamae CN; Weerasooriya MV
    Parasitology; 2000; 121 Suppl():S147-60. PubMed ID: 11386686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
    Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.
    Krentel A; Fischer P; Manoempil P; Supali T; Servais G; Rückert P
    Trop Med Int Health; 2006 Nov; 11(11):1731-40. PubMed ID: 17054754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
    Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
    Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India.
    Kshirsagar NA; Gogtay NJ; Garg BS; Deshmukh PR; Rajgor DD; Kadam VS; Kirodian BG; Ingole NS; Mehendale AM; Fleckenstein L; Karbwang J; Lazdins-Helds JK
    Trans R Soc Trop Med Hyg; 2004 Apr; 98(4):205-17. PubMed ID: 15049459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.